Suppr超能文献

腹膜癌患者CRS + HIPEC术后高肌红蛋白血症的治疗:一项回顾性比较研究。

Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study.

作者信息

Liu Gang, Ji Zhong-He, Yu Yang, Li Xin-Bao, Zhang Yan-Bin, Peng Kai-Wen, Li Yan

机构信息

Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

出版信息

Medicine (Baltimore). 2017 Nov;96(45):e8573. doi: 10.1097/MD.0000000000008573.

Abstract

This retrospective comparative study aims to explore the time courses of serum myoglobin (Mb) changes, and summarize our experience in treating patients with hypermyoglobinemia after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).This study covered 60 patients with peritoneal carcinomatosis treated with CRS + HIPEC as the study group, and another 25 cancer patients treated with conventional extensive surgery without HIPEC as the control group from February to October 2016. In the study group, patients with postoperative hypermyoglobinemia were on a comprehensive treatment regimen consisting intravenous injection of sodium bicarbonate solution according to the Mb level. In the control group, patients were recorded and treated with the same regimen except for special sodium bicarbonate solution. The preoperative and postoperative serum Mb, blood urine nitrogen (BUN), and creatinine (Cr) levels were evaluated.There were no significantly difference between the 2 groups in serum Mb, BUN, and Cr levels before surgery. Postoperative serum Mb levels were elevated in both groups and significantly higher on postoperative 0 to 2 days (P < .05) in the study group than the control group. The peak value of serum Mb levels (426.65 ± 108.386 μg/L) occurred on the surgery day. The serum Mb change rate was much bigger in the study group than the control group. Serum BUN levels in both groups revealed a slow increase during the early postoperative period and were significantly lower in the study group than the control group on days 1 and 2. The serum Cr levels were similar and stable between the 2 groups after surgery. The serum Cr change rates changed synchronously with same tendency in both groups, and on postoperative day 1 the increase rate was bigger in the control group than the study group.Hypermyoglobinemia is a common and prominent lab abnormality after CRS + HIPEC, and serum Mb levels could be an early and sensitive indicator for dramatic disturbances in the internal milieu after CRS + HIPEC. Adequate treatment with sodium bicarbonate could accelerate the reduction in serum Mb levels and reduce the risk for major organ damages.

摘要

本回顾性对照研究旨在探讨血清肌红蛋白(Mb)变化的时间过程,并总结我们在细胞减灭术(CRS)联合腹腔热灌注化疗(HIPEC)后治疗高肌红蛋白血症患者的经验。本研究纳入了2016年2月至10月期间60例接受CRS+HIPEC治疗的腹膜癌患者作为研究组,另选25例接受传统扩大手术但未行HIPEC的癌症患者作为对照组。在研究组中,术后发生高肌红蛋白血症的患者根据Mb水平接受包括静脉注射碳酸氢钠溶液在内的综合治疗方案。对照组患者除不使用特殊碳酸氢钠溶液外,采用相同方案进行记录和治疗。评估术前和术后血清Mb、血尿素氮(BUN)和肌酐(Cr)水平。两组术前血清Mb、BUN和Cr水平无显著差异。两组术后血清Mb水平均升高,且研究组术后0至2天显著高于对照组(P<0.05)。血清Mb水平峰值(426.65±108.386μg/L)出现在手术当天。研究组血清Mb变化率远大于对照组。两组血清BUN水平在术后早期均呈缓慢上升趋势,且研究组术后第1天和第2天显著低于对照组。两组术后血清Cr水平相似且稳定。两组血清Cr变化率同步且趋势相同,术后第1天对照组升高率大于研究组。高肌红蛋白血症是CRS+HIPEC术后常见且突出的实验室异常,血清Mb水平可能是CRS+HIPEC后体内环境剧烈紊乱的早期敏感指标。充分使用碳酸氢钠治疗可加速血清Mb水平下降,降低主要器官损伤风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c081/5690772/bcebe642cb89/medi-96-e8573-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验